心力衰竭患者的运动恐惧症:使用罗杰斯的进化方法进行概念分析
Zhuzhu Qin1, Huanju Liu2, Yining Tao3
1Department of Nursing, Peoples Hospital of Deyang City, Deyang, Sichuan, China.
Frontiers in cardiovascular medicine
|December 29, 2025
概括
心力衰竭 (HF) 患者的动态恐惧症涉及症状困扰,回避和认知偏见. 了解这些因素对于改善患者康复和康复结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 心理学 心理学 心理学
- 康复科学 康复科学 康复科学
背景情况:
- 运动恐惧,或对运动的恐惧,是心力衰竭 (HF) 患者的重要障碍.
- 它阻碍了身体活动,使疾病管理复杂化,并阻碍了恢复.
- 需要对运动恐惧症有明确的理解,以改善患者护理和康复策略.
研究的目的:
- 开发心力衰竭 (HF) 患者中运动恐惧症的综合概念模型.
- 使用罗杰斯的进化概念分析方法,系统地分析运动恐惧症的属性,先例和后果.
主要方法:
- 在主要数据库 (Web of Science,Embase,PubMed,CINAHL,PsycInfo) 进行了系统的文献搜索.
- 分析包括到2025年出版的30篇文章.
- 罗杰斯的进化概念分析方法指导了关键概念元素的识别.
主要成果:
- 在HF中,动态恐惧症的特征是症状困扰,复杂的情绪反应,回避行为和认知偏见.
- 前例包括人口,疾病相关,心理,身体和社会因素.
- 后果包括身体恶化,健康风险增加,心理负担和疾病管理受损.
结论:
- 这项分析加深了对心力衰竭患者的运动恐惧症的理解.
- 它强调了早期识别和有针对性的干预措施的必要性,以解决对移动的恐惧.
- 这些发现可以指导临床医生促进体育活动,增强康复坚持,并改善患者的结果.
相关概念视频
Pathophysiology of Heart Failure
2.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K
Heart Failure II: Pathophysiology
663
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
663
Heart Failure I: Introduction
657
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
657
Heart Failure IV: Classification and Diagnostic Evaluation
290
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
290
Heart Failure III: Clinical Manifestations
436
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
436
Heart Failure Drugs: Inotropic Agents
1.2K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K


